Alex C. Spyropoulos

2002–2025 年に発表

別表記
Alex C Spyropoulos
122
論文数
25,089
被引用数
66
h 指数
116
i10 指数

被引用数

Alex C. Spyropoulos の年別被引用数1998 年: 被引用 1 件2002 年: 被引用 1 件2003 年: 被引用 1 件2004 年: 被引用 6 件2005 年: 被引用 2 件2006 年: 被引用 6 件2007 年: 被引用 18 件2008 年: 被引用 25 件2009 年: 被引用 41 件2010 年: 被引用 32 件2011 年: 被引用 51 件2012 年: 被引用 78 件2013 年: 被引用 74 件2014 年: 被引用 123 件2015 年: 被引用 120 件2016 年: 被引用 124 件2017 年: 被引用 142 件2018 年: 被引用 127 件2019 年: 被引用 532 件2020 年: 被引用 1,431 件2021 年: 被引用 1,128 件2022 年: 被引用 765 件2023 年: 被引用 395 件2024 年: 被引用 589 件2025 年: 被引用 169 件2026 年: 被引用 14 件1999〜2001 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,801 件、この内訳の 21%イタリア: 引用元論文 663 件、この内訳の 7.7%イギリス: 引用元論文 620 件、この内訳の 7.2%カナダ: 引用元論文 551 件、この内訳の 6.4%ドイツ: 引用元論文 453 件、この内訳の 5.3%フランス: 引用元論文 391 件、この内訳の 4.6%スペイン: 引用元論文 355 件、この内訳の 4.1%オランダ: 引用元論文 332 件、この内訳の 3.9%中国: 引用元論文 313 件、この内訳の 3.7%スイス: 引用元論文 240 件、この内訳の 2.8%日本: 引用元論文 176 件、この内訳の 2.1%ギリシャ: 引用元論文 166 件、この内訳の 1.9%
0%21%その他 29.3%

分野

  • Medicine94.2%
  • Biochemistry, Genetics and Molecular Biology1.4%
  • Engineering1%
  • Health Professions0.9%
  • Immunology and Microbiology0.6%
  • Computer Science0.3%
  • その他1.6%

トピック

  • Venous Thromboembolism Diagnosis and Management16.4%
  • COVID-19 Clinical Research Studies11.1%
  • Atrial Fibrillation Management and Outcomes8.2%
  • Long-Term Effects of COVID-195.1%
  • Heparin-Induced Thrombocytopenia and Thrombosis3.5%
  • COVID-19 and healthcare impacts2.9%
  • その他52.8%

共著者

全論文

検索で開く
  1. Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH

    著者: , , , - Journal of Thrombosis and Haemostasis 2015 被引用: 1,366

  2. Perioperative Management of Antithrombotic Therapy

    著者: , , , , , , , , , , , , , - CHEST Journal 2022 被引用: 401

  3. Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sam Schulman - JAMA Internal Medicine 2019 被引用: 501

  4. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Veronica Dean, Christi Deaton, Çetin Erol, Robert Fagard, Roberto Ferrari, David Hasdai, Arno W. Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Patrizio Lancellotti, Aleš Linhart, Petros Nihoyannopoulos, Massimo Piepoli, Piotr Ponikowski, Per Anton Sirnes, Juan Tamargo, Michał Tendera, Adam Torbicki, William Wijns, Stephan Windecker, Document Reviewers, Çetin Erol, David Jiménez, Walter Ageno, Stefan Agewall, Riccardo Asteggiano, Rupert Bauersachs, Cecilia Becattini, Henri Bounameaux, Harry R. Büller, Constantinos H. Davos, Christi Deaton, Geert-Jan Geersing, Miguel Ángel Gómez Sánchez, Jeroen Hendriks, Arno W. Hoes, Mustafa Kılıçkap, Viacheslav Mareev, Manuel Monréal, João Morais, Petros Nihoyannopoulos, Bogdan A. Popescu, Olivier Sanchez, Alex C. Spyropoulos - European Heart Journal 2014 被引用: 3,146

  5. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John W. Eikelboom, Ido Weinberg, Sam Schulman, Marc Carrier, Gregory Piazza, Joshua A. Beckman, Philippe Gabríel Steg, Gregg W. Stone, Stephan Rosenkranz, Samuel Z. Goldhaber, Sahil A. Parikh, Manuel Monréal, Harlan M. Krumholz, Stavros Konstantinides, Jeffrey I. Weitz, Gregory Y.H. Lip - Journal of the American College of Cardiology 2020 被引用: 2,939

  6. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation

    著者: , , , , , , , , , , , , , - New England Journal of Medicine 2015 被引用: 1,164

  7. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manile Dastagir, Alex Convissar, Seerat Aujla, Elizabeth Mathew, Vani Thiyagarajan, Tricia Lewis, Luis Gruberg, Paul Maccaro, Dana Kuziw, Bhumi Pandhi, George Surguladze, Ashley M. Eapen, A. Pantea, PHYLLIS SUEN, John P. Flynt, Michael Krzyzak, Kamal Sharma, Amanda Steadham, Sherry McLean, Karen Herring, Karen Maroney, Kambiz Zorriasateyn, Bernardo Vargas‐Leitón, Marisa Durante, Ujala Bhokary, Linda Pierchala, Elizabeth A. Fisher, Debi L. Oxenberg, Alison Sabados, Omair A. Chaudhary, Shelley Schultz, S. Cotey, Connie N. Hess, Hope Cruse, Daniel Uy, Sunita Sharma, Kevin Molina, Daliya Jagat, Bandyopadhyay Dehali - JAMA Internal Medicine 2021 被引用: 486

  8. A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer-Associated Thrombosis Study

    著者: , , , , , , , , - The Oncologist 2017 被引用: 267

  9. Predictive and Associative Models to Identify Hospitalized Medical Patients at Risk for VTE

    著者: , , , , , , , , , , , , , , , , , - CHEST Journal 2011 被引用: 548

  10. Perioperative Management of Antithrombotic Therapy

    著者: , , , , , , , - CHEST Journal 2012 被引用: 1,641

  11. European Union-28: An annualised cost-of-illness model for venous thromboembolism

    著者: , , , , - Thrombosis and Haemostasis 2015 被引用: 150

  12. Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , B Hattori, Marcello da Silva Jardim, Igor Maia Marinho, Ivan S. Marinho, Liane Mara Melo Batista, Lucas Rivabem, Carlos Alberto Kenji Nakashima, Ana Carla Gois Franco, Renata Fernanda de Oliveira Pereira, Giana Caroline Strack Neves, Izara de Castro e Souza, Bruno Moraes Ribas, Flavia Ramos Tristão, Marcus Vinícius Barbosa Santos - The Lancet 2021 被引用: 252

  13. Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis

    著者: , , , , , , , , , , , , , , , , , - Journal of Thrombosis and Haemostasis 2023 被引用: 33

  14. Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient‐specific thromboembolic risk

    著者: , , , , , , , - Journal of Thrombosis and Haemostasis 2019 被引用: 142

  15. Factors at Admission Associated With Bleeding Risk in Medical Patients

    著者: , , , , , , , , , , , , , , , , , - CHEST Journal 2010 被引用: 436

  16. Global reporting of pulmonary embolism–related deaths in the World Health Organization mortality database: Vital registration data from 123 countries

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Research and Practice in Thrombosis and Haemostasis 2021 被引用: 90

  17. Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure

    著者: , , , , , , , , , - Blood Advances 2020 被引用: 67

  18. ISTH guidelines for antithrombotic treatment in COVID‐19

    著者: , , , , , , , , , , , , , , , , , - Journal of Thrombosis and Haemostasis 2022 被引用: 179

  19. Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study

    著者: , , , , , , , , , , , - Journal of Thrombosis and Haemostasis 2015 被引用: 241

  20. Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2021 被引用: 191

  21. Validation of Risk Assessment Models of Venous Thromboembolism in Hospitalized Medical Patients

    著者: , , , , , , - The American Journal of Medicine 2016 被引用: 103

  22. Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients

    著者: , , , , , , , , , , - New England Journal of Medicine 2013 被引用: 603

  23. Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists

    著者: , , , , , - Circulation 2012 被引用: 435

  24. Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study

    著者: , , , , , , , , - Journal of the American Heart Association 2020 被引用: 53